SequelSEC

Incannex Healthcare Inc. IXHL

Pharmaceutical Preparations · CIK 0001873875 · Fiscal year ends 0630

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2026-06-30
Operating income
Unavailable
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$29.10MMarket value of stock held by non-affiliates, as stated on the cover page for 2024-12-31
Float per share$0.08Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue338.4×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity2.2×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2024-12-31, not today, and each multiple below it uses the figures for the fiscal year ending 2025-06-30 — the year that filing covered.

How this compares in its industry

Percentile among the Pharmaceutical Preparations filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Revenue YoY growth-100.0%93th
Current ratio48.81x40th

This page shows 6 annual periods of income statement, balance sheet and cash flow figures normalized from Incannex Healthcare Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Incannex Healthcare Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302025-06-302025-03-312024-12-312024-09-302024-06-30
RevenueUnavailable$0$0$12.00K$74.00KUnavailable
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating incomeUnavailable-$7.53M-$5.00M-$5.00M-$6.25MUnavailable
Net incomeUnavailable-$31.60M-$3.97M-$5.89M-$5.42MUnavailable
Research & developmentUnavailable$3.70M$2.74M$1.41M$2.90MUnavailable
Weighted-average diluted sharesUnavailableUnavailableUnavailableshares 17.62Mshares 17.64MUnavailable
Pretax incomeUnavailable-$31.60M-$3.97M-$5.89M-$5.42MUnavailable
Income tax expenseUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Diluted EPSUnavailableUnavailable$-6.19$-0.33$-0.29Unavailable
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrativeUnavailable$3.83M$2.27M$3.60M$3.43MUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Incannex Healthcare Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302025-06-302025-03-312024-12-312024-09-302024-06-30
Cash & equivalents$67.71M$15.04M$6.71M$2.10M$3.63M$5.86M
Total assets$72.98M$20.45M$16.20M$11.11M$16.05M$17.05M
Current assets$72.83M$19.96M$15.63M$10.50M$15.21M$16.20M
Total liabilities$5.61M$7.06M$8.79M$10.14M$9.45M$5.83M
Current liabilities$1.49M$6.98M$7.37M$5.84M$9.23M$5.62M
Total equity incl. NCI$67.37M$13.39M$7.40M$964.00K$6.60M$11.22M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailable$2.38MUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

Incannex Healthcare Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302025-06-302025-03-312024-12-312024-09-302024-06-30
Operating cash flowUnavailable-$1.48M-$3.16M-$5.63M-$2.24MUnavailable
Capital expendituresUnavailable$0$0UnavailableUnavailableUnavailable
Investing cash flowUnavailable$0$0UnavailableUnavailableUnavailable
Financing cash flowUnavailable$9.60M$7.74M$4.10M-$52.00KUnavailable
Net change in cashUnavailableUnavailableUnavailableUnavailable-$2.23MUnavailable
Stock-based compensationUnavailable$1.30M$417.00K$435.00K$459.00KUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailable$61.00K-$5.00K$126.00K$64.00KUnavailable

Derived

Incannex Healthcare Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302025-06-302025-03-312024-12-312024-09-302024-06-30
Free cash flowUnavailable-$1.48M-$3.16MUnavailableUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailable-41700.0%-8451.4%Unavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailable3625.0%620.3%Unavailable
Current ratio48.81x2.86x2.12x1.80x1.65x2.88x
Revenue YoY growthUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailable11783.3%3913.5%Unavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open IXHL in the interactive workspace to inspect any figure back to its filing.

Source filings

10-K · Filed 2026-09-25View SEC filing
10-Q · Filed 2026-05-15View SEC filing
10-Q · Filed 2026-02-13View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-K · Filed 2025-09-29View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.